E-commerce Contacto
/contact

Hawes, Endosonografía 4 edición

Robert H. Hawes


  1. Sección IV: Páncreas y árbol biliar
  2. Cap. 14 Ultrasonido endoscópico y tumores pancreáticos
Regresar

Capítulo 14 Ultrasonido endoscópico y tumores pancreáticos.

  1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
  2. Mertz HR, Sechopoulos P, Delbeke Det al., et al. EUS, PET, and CT scanning for evaluation of pancreatic adenocarcinoma. Gastrointest Endosc. 2000;52:367–371.
  3. Ainsworth AP, Rafaelsen SR, Wamberg PAet al., et al. Is there a difference in diagnostic accuracy and clinical impact between endoscopic ultrasonography and magnetic resonance cholangiopancreatography? Endoscopy. 2003;35:1029–1032.
  4. Agarwal B, Abu-Hamda E, Molke KLet al., et al. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol. 2004;99:844–850.
  5. Best LM, Rawji V, Pereira SPet al., et al. Imaging modalities for characterising focal pancreatic lesions. Cochrane Database Syst Rev. 2017;4:Cd010213.
  6. Muller MF, Meyenberger C, Bertschinger Pet al., et al. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology. 1994;190:745–751.
  7. Catanzaro A, Richardson S, Veloso Het al., et al. Long-term follow-up of patients with clinically indeterminate suspicion of pancreatic cancer and normal EUS. Gastrointest Endosc. 2003;58:836–840.
  8. Klapman JB, Chang KJ, Lee JGet al., et al. Negative predictive value of endoscopic ultrasound in a large series of patients with a clinical suspicion of pancreatic cancer. Am J Gastroenterol. 2005;100:2658–2661.
  9. Lee ES, Lee JM. Imaging diagnosis of pancreatic cancer: a state-of-the-art review. World J Gastroenterol. 2014;20:7864–7877.
  10. Schima W, Ba-Ssalamah A, Kolblinger Cet al., et al. Pancreatic adenocarcinoma. Eur Radiol. 2007;17:638–649.
  11. DeWitt J, Devereaux B, Chriswell Met al., et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med. 2004;141:753–763.
  12. Koelblinger C, Ba-Ssalamah A, Goetzinger Pet al., et al. Gadobenate dimeglumine-enhanced 3.0-T MR imaging versus multiphasic 64-detector row CT: prospective evaluation in patients suspected of having pancreatic cancer. Radiology. 2011;259:757–766.
  13. Lee JK, Kim AY, Kim PNet al., et al. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma. Eur J Radiol. 2010;73:310–316.
  14. Irie H, Honda H, Kaneko Ket al., et al. Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma. Abdom Imaging. 1997;22:429–433.
  15. Bronstein YL, Loyer EM, Kaur Het al., et al. Detection of small pancreatic tumors with multiphasic helical CT. AJR Am J Roentgenol. 2004;182:619–623.
  16. Midwinter MJ, Beveridge CJ, Wilsdon JBet al., et al. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg. 1999;86:189–193.
  17. Dewitt J, Devereaux BM, Lehman GAet al., et al. Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review. Clin Gastroenterol Hepatol. 2006;4:717–725. quiz 664.
  18. Yasuda I, Iwashita T, Doi Set al., et al. Role of EUS in the early detection of small pancreatic cancer. Dig Endosc. 2011;23(suppl 1):22–25.
  19. Yoon SH, Lee JM, Cho JYet al., et al. Small (</= 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology. 2011;259:442–452.
  20. Wang W, Shpaner A, Krishna SGet al., et al. Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT. Gastrointest Endosc. 2013;78:73–80.
  21. Krishna SG, Rao BB, Ugbarugba Eet al., et al. Diagnostic performance of endoscopic ultrasound for detection of pancreatic malignancy following an indeterminate multidetector CT scan: a systemic review and meta-analysis. Surg Endosc. 2017;31:4558–4567.
  22. Rieber A, Tomczak R, Nussle Ket al., et al. MRI with mangafodipir trisodium in the detection of pancreatic tumours: comparison with helical CT. Br J Radiol. 2000;73:1165–1169.
  23. Kauhanen SP, Komar G, Seppanen MPet al., et al. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Ann Surg. 2009;250:957–963.
  24. Soriano A, Castells A, Ayuso Cet al., et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol. 2004;99:492–501.
  25. Kitano M, Kamata K, Imai Het al., et al. Contrast-enhanced harmonic endoscopic ultrasonography for pancreatobiliary diseases. Dig Endosc. 2015;27(suppl 1):60–67.
  26. Saftoiu A, Vilmann P, Dietrich CFet al., et al. Quantitative contrast-enhanced harmonic EUS in differential diagnosis of focal pancreatic masses (with videos). Gastrointest Endosc. 2015;82:59–69.
  27. Fusaroli P, Spada A, Mancino MGet al., et al. Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses. Clin Gastroenterol Hepatol. 2010;8. 629–634.e1–e2.
  28. Gong TT, Hu DM, Zhu Q. Contrast-enhanced EUS for differential diagnosis of pancreatic mass lesions: a meta-analysis. Gastrointest Endosc. 2012;76:301–309.
  29. Sugimoto M, Takagi T, Hikichi Tet al., et al. Conventional versus contrast-enhanced harmonic endoscopic ultrasonography-guided fine-needle aspiration for diagnosis of solid pancreatic lesions: a prospective randomized trial. Pancreatology. 2015;15:538–541.
  30. Janssen J, Schlorer E, Greiner L. EUS elastography of the pancreas: feasibility and pattern description of the normal pancreas, chronic pancreatitis, and focal pancreatic lesions. Gastrointest Endosc. 2007;65:971–978.
  31. Iglesias-Garcia J, Larino-Noia J, Abdulkader Iet al., et al. Quantitative endoscopic ultrasound elastography: an accurate method for the differentiation of solid pancreatic masses. Gastroenterology. 2010;139:1172–1180.
  32. Mei M, Ni J, Liu Det al., et al. EUS elastography for diagnosis of solid pancreatic masses: a meta-analysis. Gastrointest Endosc. 2013;77:578–589.
  33. Ying L, Lin X, Xie ZLet al., et al. Clinical utility of endoscopic ultrasound elastography for identification of malignant pancreatic masses: a meta-analysis. J Gastroenterol Hepatol. 2013;28:1434–1443.
  34. Li X, Xu W, Shi Jet al., et al. Endoscopic ultrasound elastography for differentiating between pancreatic adenocarcinoma and inflammatory masses: a meta-analysis. World J Gastroenterol. 2013;19:6284–6291.
  35. Hu DM, Gong TT, Zhu Q. Endoscopic ultrasound elastography for differential diagnosis of pancreatic masses: a meta-analysis. Dig Dis Sci. 2013;58:1125–1131.
  36. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg. 1996;223:273–279.
  37. Wagner M, Redaelli C, Lietz Met al., et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586–594.
  38. Kamarajah SK, Burns WR, Frankel TLet al., et al. Validation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with pancreatic adenocarcinoma: a Surveillance, Epidemiology and End Results (SEER) analysis. Ann Surg Oncol. 2017;24:2023–2030.
  39. Gilbert JW, Wolpin B, Clancy Tet al., et al. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification. Ann Oncol. 2017;28:2067–2076.
  40. Tempero MA, Malafa MP, Behrman SWet al., et al. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2014;12:1083–1093.
  41. Tamburrino D, Partelli S, Crippa Set al., et al. Selection criteria in resectable pancreatic cancer: a biological and morphological approach. World J Gastroenterol. 2014;20:11210–11215.
  42. Howard TJ, Chin AC, Streib EWet al., et al. Value of helical computed tomography, angiography, and endoscopic ultrasound in determining resectability of periampullary carcinoma. Am J Surg. 1997;174:237–241.
  43. Tellez-Avila FI, Chavez-Tapia NC, Lopez-Arce Get al., et al. Vascular invasion in pancreatic cancer: predictive values for endoscopic ultrasound and computed tomography imaging. Pancreas. 2012;41:636–638.
  44. Sugiyama M, Hagi H, Atomi Yet al., et al. Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography. Abdom Imaging. 1997;22:434–438.
  45. Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc. 1997;45:474–479.
  46. Catalano MF, Sivak Jr. MV, Rice Tet al., et al. Endosonographic features predictive of lymph node metastasis. Gastrointest Endosc. 1994;40:442–446.
  47. Nawaz H, Fan CY, Kloke Jet al., et al. Performance characteristics of endoscopic ultrasound in the staging of pancreatic cancer: a meta-analysis. JOP. 2013;14:484–497.
  48. Smith SL, Rajan PS. Imaging of pancreatic adenocarcinoma with emphasis on multidetector CT. Clin Radiol. 2004;59:26–38.
  49. Nguyen P, Feng JC, Chang KJ. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration (FNA) of liver lesions. Gastrointest Endosc. 1999;50:357–361.
  50. tenBerge J, Hoffman BJ, Hawes RHet al., et al. EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases. Gastrointest Endosc. 2002;55:859–862.
  51. Holzapfel K, Reiser-Erkan C, Fingerle AAet al., et al. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer. Abdom Imaging. 2011;36:179–184.
  52. Motosugi U, Ichikawa T, Morisaka Het al., et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology. 2011;260:446–453.
  53. Nguyen PT, Chang KJ. EUS in the detection of ascites and EUS-guided paracentesis. Gastrointest Endosc. 2001;54:336–339.
  54. Coley SC, Strickland NH, Walker JDet al., et al. Spiral CT and the pre-operative assessment of pancreatic adenocarcinoma. Clin Radiol. 1997;52:24–30.
  55. O’Malley ME, Boland GW, Wood BJet al., et al. Adenocarcinoma of the head of the pancreas: determination of surgical unresectability with thin-section pancreatic-phase helical CT. AJR Am J Roentgenol. 1999;173:1513–1518.
  56. Al-Hawary MM, Francis IR, Chari STet al., et al. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology. 2014;146:291–304.e1.
  57. Kaneko OF, Lee DM, Wong Jet al., et al. Performance of multidetector computed tomographic angiography in determining surgical resectability of pancreatic head adenocarcinoma. J Comput Assist Tomogr. 2010;34:732–738.
  58. Kala Z, Valek V, Hlavsa Jet al., et al. The role of CT and endoscopic ultrasound in pre-operative staging of pancreatic cancer. Eur J Radiol. 2007;62:166–169.
  59. Chen G, Liu S, Zhao Yet al., et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer: a meta-analysis. Pancreatology. 2013;13:298–304.
  60. Hewitt MJ, McPhail MJ, Possamai Let al., et al. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc. 2012;75:319–331.
  61. Puli SR, Bechtold ML, Buxbaum JLet al., et al. How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: a meta-analysis and systematic review. Pancreas. 2013;42:20–26.
  62. Hebert-Magee S, Bae S, Varadarajulu Set al., et al. The presence of a cytopathologist increases the diagnostic accuracy of endoscopic ultrasound-guided fine needle aspiration cytology for pancreatic adenocarcinoma: a meta-analysis. Cytopathology. 2013;24:159–171.
  63. Dumonceau JM, Deprez PH, Jenssen Cet al., et al. Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline—Updated January 2017. Endoscopy. 2017;49:695–714.
  64. Madhoun MF, Wani SB, Rastogi Aet al., et al. The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis. Endoscopy. 2013;45:86–92.
  65. Camellini L, Carlinfante G, Azzolini Fet al., et al. A randomized clinical trial comparing 22G and 25G needles in endoscopic ultrasound-guided fine-needle aspiration of solid lesions. Endoscopy. 2011;43:709–715.
  66. Fabbri C, Polifemo AM, Luigiano Cet al., et al. Endoscopic ultrasound-guided fine needle aspiration with 22- and 25-gauge needles in solid pancreatic masses: a prospective comparative study with randomisation of needle sequence. Dig Liver Dis. 2011;43:647–652.
  67. Siddiqui UD, Rossi F, Rosenthal LSet al., et al. EUS-guided FNA of solid pancreatic masses: a prospective, randomized trial comparing 22-gauge and 25-gauge needles. Gastrointest Endosc. 2009;70:1093–1097.
  68. Bang JY, Hebert-Magee S, Hasan MKet al., et al. Randomized trial comparing the 22 and 25 gauge needles using the suction-in and no-suction (SINS) techniques for EUS-guided FNA of pancreatic masses. United European Gastroenterology Journal. 2016;4:A12.
  69. Bang JY, Ramesh J, Trevino Jet al., et al. Objective assessment of an algorithmic approach to EUS-guided FNA and interventions. Gastrointest Endosc. 2013;77:739–744.
  70. Lee JK, Choi JH, Lee KHet al., et al. A prospective, comparative trial to optimize sampling techniques in EUS-guided FNA of solid pancreatic masses. Gastrointest Endosc. 2013;77:745–751.
  71. Puri R, Vilmann P, Saftoiu Aet al., et al. Randomized controlled trial of endoscopic ultrasound-guided fine-needle sampling with or without suction for better cytological diagnosis. Scand J Gastroenterol. 2009;44:499–504.
  72. Abe Y, Kawakami H, Oba Ket al., et al. Effect of a stylet on a histological specimen in EUS-guided fine-needle tissue acquisition by using 22-gauge needles: a multicenter, prospective, randomized, controlled trial. Gastrointest Endosc. 2015;82:837–844.e1.
  73. Rastogi A, Wani S, Gupta Net al., et al. A prospective, single-blind, randomized, controlled trial of EUS-guided FNA with and without a stylet. Gastrointest Endosc. 2011;74:58–64.
  74. Sahai AV, Paquin SC, Gariepy G. A prospective comparison of endoscopic ultrasound-guided fine needle aspiration results obtained in the same lesion, with and without the needle stylet. Endoscopy. 2010;42:900–903.
  75. Gimeno-Garcia AZ, Paquin SC, Gariepy Get al., et al. Comparison of endoscopic ultrasonography-guided fine-needle aspiration cytology results with and without the stylet in 3364 cases. Dig Endosc. 2013;25:303–307.
  76. Klapman JB, Logrono R, Dye CEet al., et al. Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. Am J Gastroenterol. 2003;98:1289–1294.
  77. Varadarajulu S, Bang JY, Holt BAet al., et al. The 25-gauge EUS-FNA needle: Good for on-site but poor for off-site evaluation? Results of a randomized trial. Gastrointest Endosc. 2014;80:1056–1063.
  78. Ramesh J, Varadarajulu S. How can we get the best results with endoscopic ultrasound-guided fine needle aspiration? Clin Endosc. 2012;45:132–137.
  79. Varadarajulu S, Tamhane A, Eloubeidi MA. Yield of EUS-guided FNA of pancreatic masses in the presence or the absence of chronic pancreatitis. Gastrointest Endosc. 2005;62:728–736. quiz 751, 753.
  80. Fritscher-Ravens A, Brand L, Knofel WTet al., et al. Comparison of endoscopic ultrasound-guided fine needle aspiration for focal pancreatic lesions in patients with normal parenchyma and chronic pancreatitis. Am J Gastroenterol. 2002;97:2768–2775.
  81. Eloubeidi MA, Varadarajulu S, Desai Set al., et al. Value of repeat endoscopic ultrasound-guided fine needle aspiration for suspected pancreatic cancer. J Gastroenterol Hepatol. 2008;23:567–570.
  82. Wang KX, Ben QW, Jin ZDet al., et al. Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. Gastrointest Endosc. 2011;73:283–290.
  83. Micames C, Jowell PS, White Ret al., et al. Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs. percutaneous FNA. Gastrointest Endosc. 2003;58:690–695.
  84. Eloubeidi MA, Chen VK, Eltoum IAet al., et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol. 2003;98:2663–2668.
  85. Ribeiro A, Vazquez-Sequeiros E, Wiersema LMet al., et al. EUS-guided fine-needle aspiration combined with flow cytometry and immunocytochemistry in the diagnosis of lymphoma. Gastrointest Endosc. 2001;53:485–491.
  86. Wakatsuki T, Irisawa A, Terashima Met al., et al. ATP assay-guided chemosensitivity testing for gemcitabine with biopsy specimens obtained from unresectable pancreatic cancer using endoscopic ultrasonography-guided fine-needle aspiration. Int J Clin Oncol. 2011;16:387–394.
  87. Brais RJ, Davies SE, O’Donovan Met al., et al. Direct histological processing of EUS biopsies enables rapid molecular biomarker analysis for interventional pancreatic cancer trials. Pancreatology. 2012;12:8–15.
  88. Bang JY, Hawes R, Varadarajulu S. A meta-analysis comparing ProCore and standard fine-needle aspiration needles for endoscopic ultrasound-guided tissue acquisition. Endoscopy. 2016;48:339–349.
  89. Kandel P, Tranesh G, Nassar Aet al., et al. EUS-guided fine needle biopsy sampling using a novel fork-tip needle: a case-control study. Gastrointest Endosc. 2016;84:1034–1039.
  90. Bang JY, Hebert-Magee S, Hasan MKet al., et al. Endoscopic ultrasonography-guided biopsy using a franseen needle design: initial assessment. Dig Endosc. 2017;29:338–346.
  91. Bang JY, Hebert-Magee S, Hasan MKet al., et al. Randomized trial comparing the 22G franseen biopsy and 22G aspiration needles for EUS-guided sampling of solid pancreatic mass lesions; 2017.
  92. Yao JC, Hassan M, Phan Aet al., et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–3072.
  93. Salaria SN, Shi C. Pancreatic neuroendocrine tumors. Surg Pathol Clin. 2016;9:595–617.
  94. Öberg K, Knigge U, Kwekkeboom Det al., et al. Neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Annals of Oncology. 2012;23. vii124–vii130.
  95. Khashab MA, Yong E, Lennon AMet al., et al. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest Endosc. 2011;73:691–696.
  96. Thoeni RF, Mueller-Lisse UG, Chan Ret al., et al. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology. 2000;214:483–490.
  97. van Asselt SJ, Brouwers AH, van Dullemen HMet al., et al. EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1. Gastrointest Endosc. 2015;81:159–167.e2.
  98. Sadowski SM, Neychev V, Millo Cet al., et al. Prospective study of 68Ga-DOTATATE positron emission tomography/computed tomography for detecting gastro-entero-pancreatic neuroendocrine tumors and unknown primary sites. J Clin Oncol. 2016;34:588–596.
  99. Kimura N, Pilichowska M, Date Fet al., et al. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors. Clin Cancer Res. 1999;5:3483–3487.
  100. De Angelis C, Carucci P, Repici Aet al., et al. Endosonography in decision making and management of gastrointestinal endocrine tumors. Eur J Ultrasound. 1999;10:139–150.
  101. Proye C, Malvaux P, Pattou Fet al., et al. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery. 1998;124:1134–1143. discussion 1143–1144.
  102. Zimmer T, Stolzel U, Bader Met al., et al. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut. 1996;39:562–568.
  103. Termanini B, Gibril F, Reynolds JCet al., et al. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterology. 1997;112:335–347.
  104. Dromain C, de Baere T, Baudin Eet al., et al. MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. AJR Am J Roentgenol. 2003;180:121–128.
  105. Dromain C, de Baere T, Lumbroso Jet al., et al. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol. 2005;23:70–78.
  106. Anderson MA, Carpenter S, Thompson NWet al., et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol. 2000;95:2271–2277.
  107. Fujimori N, Osoegawa T, Lee Let al., et al. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors. Scand J Gastroenterol. 2016;51:245–252.
  108. James PD, Tsolakis AV, Zhang Met al., et al. Incremental benefit of preoperative EUS for the detection of pancreatic neuroendocrine tumors: a meta-analysis. Gastrointest Endosc. 2015;81:848–856.e1.
  109. Puli SR, Kalva N, Bechtold MLet al., et al. Diagnostic accuracy of endoscopic ultrasound in pancreatic neuroendocrine tumors: a systematic review and meta analysis. World J Gastroenterol. 2013;19:3678–3684.
  110. Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc. 2004;60:378–384.
  111. Hellman P, Hennings J, Akerstrom Get al., et al. Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1. Br J Surg. 2005;92:1508–1512.
  112. Barbe C, Murat A, Dupas Bet al., et al. Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1. Dig Liver Dis. 2012;44:228–234.
  113. Gines A, Vazquez-Sequeiros E, Soria MTet al., et al. Usefulness of EUS-guided fine needle aspiration (EUS-FNA) in the diagnosis of functioning neuroendocrine tumors. Gastrointest Endosc. 2002;56:291–296.
  114. Ridtitid W, Halawi H, DeWitt JMet al., et al. Cystic pancreatic neuroendocrine tumors: outcomes of preoperative endosonography-guided fine needle aspiration, and recurrence during long-term follow-up. Endoscopy. 2015;47:617–625.
  115. Hasegawa T, Yamao K, Hijioka Set al., et al. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy. 2014;46:32–38.
  116. Diaz Del Arco C, Esteban Lopez-Jamar JM, Ortega Medina Let al., et al. Fine-needle aspiration biopsy of pancreatic neuroendocrine tumors: correlation between Ki-67 index in cytological samples and clinical behavior. Diagn Cytopathol. 2017;45:29–35.
  117. Lakhtakia S, Ramchandani M, Galasso Det al., et al. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos). Gastrointest Endosc. 2016;83:234–239.
  118. Pai M, Habib N, Senturk Het al., et al. Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors. World J Gastrointest Surg. 2015;7:52–59.
  119. Teoh AY, Chong CC, Chan AWet al., et al. EUS-guided alcohol injection of pancreatic neuroendocrine tumor. Gastrointest Endosc. 2015;82:167.
  120. Raymond SLT, Yugawa D, Chang KHFet al., et al. Metastatic neoplasms to the pancreas diagnosed by fine-needle aspiration/biopsy cytology: a 15-year retrospective analysis. Diagn Cytopathol. 2017;45:771–783.
  121. Layfield LJ, Hirschowitz SL, Adler DG. Metastatic disease to the pancreas documented by endoscopic ultrasound guided fine-needle aspiration: a seven-year experience. Diagn Cytopathol. 2012;40:228–233.
  122. Atiq M, Bhutani MS, Ross WAet al., et al. Role of endoscopic ultrasonography in evaluation of metastatic lesions to the pancreas: a tertiary cancer center experience. Pancreas. 2013;42:516–523.
  123. El II H, LeBlanc JK, Sherman Set al., et al. Endoscopic ultrasound-guided biopsy of pancreatic metastases: a large single-center experience. Pancreas. 2013;42:524–530.
  124. Sekulic M, Amin K, Mettler Tet al., et al. Pancreatic involvement by metastasizing neoplasms as determined by endoscopic ultrasound-guided fine needle aspiration: a clinicopathologic characterization. Diagn Cytopathol. 2017;45:418–425.
  125. Alomari AK, Ustun B, Aslanian HRet al., et al. Endoscopic ultrasound-guided fine-needle aspiration diagnosis of secondary tumors involving the pancreas: an institution’s experience. Cytojournal. 2016;13:1.
  126. Pannala R, Hallberg-Wallace KM, Smith ALet al., et al. Endoscopic ultrasound-guided fine needle aspiration cytology of metastatic renal cell carcinoma to the pancreas: a multi-center experience. Cytojournal. 2016;13:24.
  127. Sperti C, Pasquali C, Liessi Get al., et al. Pancreatic resection for metastatic tumors to the pancreas. J Surg Oncol. 2003;83:161–166. discussion 166.
  128. Palazzo L, Borotto E, Cellier Cet al., et al. Endosonographic features of pancreatic metastases. Gastrointest Endosc. 1996;44:433–436.
  129. DeWitt J, Jowell P, Leblanc Jet al., et al. EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc. 2005;61:689–696.
  130. Hijioka S, Hara K, Mizuno Net al., et al. Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms. J Gastroenterol. 2016;51:923–930.
  131. Fritscher-Ravens A, Sriram PV, Krause Cet al., et al. Detection of pancreatic metastases by EUS-guided fine-needle aspiration. Gastrointest Endosc. 2001;53:65–70.
  132. Ramesh J, Hebert-Magee S, Kim Het al., et al. Frequency of occurrence and characteristics of primary pancreatic lymphoma during endoscopic ultrasound guided fine needle aspiration: a retrospective study. Dig Liver Dis. 2014;46:470–473.
  133. Moffitt RA, Marayati R, Flate ELet al., et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat Genet. 2015;47:1168–1178.
  134. Sato N, Cheng XB, Kohi Set al., et al. Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma. Acta Pharm Sin B. 2016;6:101–105.
  135. Jacobetz MA, Chan DS, Neesse Aet al., et al. Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer. Gut. 2013;62:112–120.
Regresar